Literature DB >> 33727705

Isoform-dependent APOE secretion modulates neuroinflammation.

Philip Hasel1, Shane A Liddelow2,3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33727705     DOI: 10.1038/s41582-021-00483-y

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN: 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  1 in total

1.  Expression and secretion of apoE isoforms in astrocytes and microglia during inflammation.

Authors:  Maria Fe Lanfranco; Jordy Sepulveda; Gregory Kopetsky; G William Rebeck
Journal:  Glia       Date:  2021-02-08       Impact factor: 8.073

  1 in total
  4 in total

1.  Presenilin Is Essential for ApoE Secretion, a Novel Role of Presenilin Involved in Alzheimer's Disease Pathogenesis.

Authors:  Sadequl Islam; Yang Sun; Yuan Gao; Tomohisa Nakamura; Arshad Ali Noorani; Tong Li; Philip C Wong; Noriyuki Kimura; Etsuro Matsubara; Kensaku Kasuga; Takeshi Ikeuchi; Taisuke Tomita; Kun Zou; Makoto Michikawa
Journal:  J Neurosci       Date:  2022-01-05       Impact factor: 6.709

Review 2.  Solving neurodegeneration: common mechanisms and strategies for new treatments.

Authors:  Lauren K Wareham; Shane A Liddelow; Sally Temple; Larry I Benowitz; Adriana Di Polo; Cheryl Wellington; Jeffrey L Goldberg; Zhigang He; Xin Duan; Guojun Bu; Albert A Davis; Karthik Shekhar; Anna La Torre; David C Chan; M Valeria Canto-Soler; John G Flanagan; Preeti Subramanian; Sharyn Rossi; Thomas Brunner; Diane E Bovenkamp; David J Calkins
Journal:  Mol Neurodegener       Date:  2022-03-21       Impact factor: 18.879

3.  Dementia risk and dynamic response to exercise: A non-randomized clinical trial.

Authors:  Eric D Vidoni; Jill K Morris; Jacqueline A Palmer; Yanming Li; Dreu White; Paul J Kueck; Casey S John; Robyn A Honea; Rebecca J Lepping; Phil Lee; Jonathan D Mahnken; Laura E Martin; Sandra A Billinger
Journal:  PLoS One       Date:  2022-07-08       Impact factor: 3.752

Review 4.  Are apolipoprotein E fragments a promising new therapeutic target for Alzheimer's disease?

Authors:  Filomena Lo Vecchio; Paola Bisceglia; Bruno Pietro Imbimbo; Madia Lozupone; Raffaela Rita Latino; Emanuela Resta; Maurizio Leone; Vincenzo Solfrizzi; Antonio Greco; Antonio Daniele; Mark Watling; Francesco Panza; Davide Seripa
Journal:  Ther Adv Chronic Dis       Date:  2022-03-17       Impact factor: 5.091

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.